Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Advanced Course on NTRK Gene Fusion: A New Target in Precision Treatment of Cancer 2021

Advanced Course on NTRK Gene Fusion 1000x250
Start date
06 Dec 2021
End date
07 Dec 2021
Location
Virtual, GMT +8
Application deadline
25 Oct 2021

Please kindly note that the virtual course programme timings are to be considered GMT+8.

Learning objectives

  • Acquire knowledge of the TRK family members and their roles in ontogenesis
  • Understand the mechanisms of gene fusion and the different fusion partners involved
  • Learn how TRK receptors are structured and how their activation impacts signal transduction
  • Review the epidemiology of NTRK gene fusion in human tumours
  • Understand the methodology to identify NTRK gene fusion and the challenges of testing
  • Update knowledge on the present outcome obtained with NTRK inhibitors, their toxicities and clinical management

Download the preliminary programme 

Apply now!

How to apply

Application is via online form. During the application process you will be required to upload the following:

  • Your CV including a list of your publications

Application deadline

Application for the online course will close on 25 October 2021

Who can apply?

While this course is primarily aimed at experienced oncologists and pathologists resident in Japan and Asia, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary registration for this virtual course.

Accreditation

The programme of this virtual event will be accredited with ESMO-MORA category 1 points Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

  • Tsuyoshi Saito, Japan
  • Silvia Stacchiotti, Italy
  • Iain Bee Huat Tan, Singapore

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings